MarketLens MarketLens
US: 2026-06-12 NSE: 2026-06-12 2026-06-14
Negative
Menu

Stock Lookup

Search by symbol or company name, then inspect the chart and stock properties.

US

FATE Fate Therapeutics, Inc.

TradingView As Of 6/12/26
Analyst Data
Refresh analyst earnings estimates and rating summary for this symbol only.
Close
2.0699
Day %
5.07%
RS
N/A
RS 1D
N/A
RS 1W
N/A
RS 1M
N/A
RS 3M
N/A
RS 6M
N/A
Consensus Rating
Hold
Current Quarter EPS
-0.30
Next Quarter EPS
-0.31
Current Year EPS
-1.13
Next Year EPS
-1.02
ExchangeUS
Market Cap0 B
52W High2.8800
From 52W High-28.13%
Open1.9900
High2.1591
Low1.9300
OptionsNo
ActiveYes
RS TypeFull
RS Date2026-06-12
Bars Available309
Scanner Hits2
Last Scanner Hit2026-05-05

Recent Scanner History

2 matching / 2 total
Reset
Date Scanner RS
2026-05-05 Bull Snort
US_BULL_SNORT
N/A
2026-05-01 Bull Snort
US_BULL_SNORT
N/A

Analyst Snapshot

As Of 3/29/26
Consensus Current Quarter EPS Next Quarter EPS Current Year EPS Next Year EPS
Hold -0.30 -0.31 -1.13 -1.02
Based on 21 analysts offering recommendations for 'FATE'.

Quarterly EPS Forecasts

5 rows
Period Consensus EPS High Low Estimates Revisions
Mar 2026 -0.30 -0.27 -0.31 6
2 0
Jun 2026 -0.31 -0.29 -0.32 4
1 0
Sep 2026 -0.30 -0.25 -0.33 4
1 0
Dec 2026 -0.31 -0.25 -0.33 4
1 0
Mar 2027 -0.30 -0.26 -0.33 3
0 0

Yearly EPS Forecasts

4 rows
Period Consensus EPS High Low Estimates Revisions
Dec 2026 -1.13 -0.64 -1.31 8
1 5
Dec 2027 -1.02 -0.36 -1.44 6
2 1
Dec 2028 -0.96 -0.60 -1.32 2
2 0
Dec 2029 -0.91 -0.51 -1.31 2
2 0